Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wirth

Showing results (661-670 of 675) with videos related to

Pageof 68
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|December 16, 2014
Thyroid carcinoma, version 2.2014R Michael Tuttle, Robert I Haddad, Douglas W Ball, et al.
Journal for Immunotherapy of Cancer|April 20, 2025
Reversible downregulation of HLA class I in adenoid cystic carcinomaAnnie Li, Bianca L Gonda, Elizabeth M Codd, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 12, 2015
Anaplastic Thyroid Carcinoma, Version 2.2015Robert I Haddad, William M Lydiatt, Douglas W Ball, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2018
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018Robert I Haddad, Christian Nasr, Lindsay Bischoff, et al.
Cancer Discovery|January 8, 2026
Acquired on-target alterations drive clinical resistance to p53-Y220C reactivatorsFerran Fece de la Cruz, Andreas Varkaris, Parasvi S Patel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trialH C Toh, M-H Yang, H-M Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2025
Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck CancersMichael E Bryan, Ling Aye, Dipon Das, et al.
Head & Neck|March 11, 2022
American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatmentDavid C Shonka, Alan Ho, Ashish V Chintakuntlawar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyRobert I Haddad, Lindsay Bischoff, Douglas Ball, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2025
NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025Robert I Haddad, Lindsay Bischoff, Megan Applewhite, et al.
Pageof 68

Showing results (661-670 of 675) with videos related to

Sort By:
Pageof 68
Journal of the National Comprehensive Cancer Network : JNCCN|December 16, 2014
Thyroid carcinoma, version 2.2014R Michael Tuttle, Robert I Haddad, Douglas W Ball, et al.
Journal for Immunotherapy of Cancer|April 20, 2025
Reversible downregulation of HLA class I in adenoid cystic carcinomaAnnie Li, Bianca L Gonda, Elizabeth M Codd, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 12, 2015
Anaplastic Thyroid Carcinoma, Version 2.2015Robert I Haddad, William M Lydiatt, Douglas W Ball, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2018
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018Robert I Haddad, Christian Nasr, Lindsay Bischoff, et al.
Cancer Discovery|January 8, 2026
Acquired on-target alterations drive clinical resistance to p53-Y220C reactivatorsFerran Fece de la Cruz, Andreas Varkaris, Parasvi S Patel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trialH C Toh, M-H Yang, H-M Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2025
Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck CancersMichael E Bryan, Ling Aye, Dipon Das, et al.
Head & Neck|March 11, 2022
American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatmentDavid C Shonka, Alan Ho, Ashish V Chintakuntlawar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyRobert I Haddad, Lindsay Bischoff, Douglas Ball, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2025
NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025Robert I Haddad, Lindsay Bischoff, Megan Applewhite, et al.
Pageof 68